Hologic (HOLX)
(Delayed Data from NSDQ)
$73.48 USD
-0.05 (-0.07%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $73.40 -0.08 (-0.11%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
Hologic (HOLX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$85.83 | $95.00 | $78.00 | 16.73% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Hologic comes to $85.83. The forecasts range from a low of $78.00 to a high of $95.00. The average price target represents an increase of 16.73% from the last closing price of $73.53.
Analyst Price Targets (12)
Broker Rating
Hologic currently has an average brokerage recommendation (ABR) of 1.93 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on 14 recommendations.
Of the 15 recommendations deriving the current ABR, seven are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 46.67% and 13.33% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 6 | 6 | 5 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.93 | 1.93 | 2.00 | 2.00 | 2.08 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/27/2024 | Stephens | Mason Carrico | Not Available | Strong Buy |
6/17/2024 | Not Identified | Not Identified | Hold | Hold |
5/9/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
5/3/2024 | Raymond James | Andrew Cooper | Moderate Buy | Moderate Buy |
4/12/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
4/10/2024 | Needham & Company | Michael Matson | Moderate Buy | Moderate Buy |
4/4/2024 | Evercore Partners | Vijay Kumar | Hold | Hold |
4/3/2024 | Not Identified | Not Identified | Hold | Strong Buy |
1/12/2024 | UBS | Dan Leonard | Not Available | Hold |
1/8/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
10/17/2023 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.93 |
ABR (Last week) | 1.93 |
# of Recs in ABR | 15 |
Average Target Price | $85.83 |
LT Growth Rate | 7.40% |
Industry | Medical - Instruments |
Industry Rank by ABR | 154 of 252 |
Current Quarter EPS Est: | 1.02 |